Ignyta Acquires Actagene Oncology for Undisclosed Sum

  • Feed Type
  • Date
    5/21/2013
  • Company Name
    Actagene Oncology
  • Mailing Address
    Undisclosed San Diego, CA 92121
  • Company Description
    Actagene is developing personalized medicines for high unmet need cancer indications, based on cancer genome mining and sequencing.
  • Website
    Undisclosed
  • Transaction Type
    M&A
  • Transaction Amount
    Undisclosed
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    Financial terms of the transaction were not disclosed by the parties.